Skip to content

Company · founded 2010

Inhibrx (United States)

La Jolla, United States · inhibrx.com

Manage this page

Citations, last 5 years: 360
Works, last 5 years: 42
h-index: 29
Scientists listed: 11
Grants since 2016: 5

Grants received

2017–2019 · research · R43

Development of Multispecific Antibodies for the treatment of Methicillin Resistant Staphylococcus ‎aureus (MRSA) infection

Andrew Stephen Hollands · Inhibrx (United States) · funded by National Institutes of Health

$116k

2017 · research · R44

Development of multispecific antibodies for the treatment of Pseudomonas aeruginosa infection

Andrew Stephen Hollands · Inhibrx (United States) · funded by National Institutes of Health

$223.9k

2017–2019 · research · R44

Development of multispecific antibodies for the treatment of Pseudomonas aeruginosa infection

Andrew Stephen Hollands · Inhibrx (United States) · funded by National Institutes of Health

$936.9k

2017–2018 · research · R44

Development of multispecific antibodies for the treatment of Pseudomonas aeruginosa infection

Andrew Stephen Hollands · Inhibrx (United States) · funded by National Institutes of Health

$63.4k

2017–2018 · research · R43

Development of Multispecific Antibodies for the treatment of Methicillin Resistant Staphylococcus ‎aureus (MRSA) infection

Andrew Stephen Hollands · Inhibrx (United States) · funded by National Institutes of Health

$108.4k